Xencor (XNCR)
24.90
-0.26 (1.03%)
Upcoming Events
Latest Headlines
Xencor to webcast Phase 1 results of XmAb819 in kidney cancer
October 19, 2026 7:01 AM - StreetInsider
Xencor to Host Webcast to Discuss Results From the Phase 1 Study of XmAb819 in Advanced Clear Cell Renal Cell Carcinoma
October 19, 2026 7:01 AM - BizWire
RBC: 'ESMO is likely the biggest event for MRK/MRNA for the rest of this year'
October 16, 2026 10:51 AM - StreetInsider
Raymond James Updates Healthcare Top Picks for October
October 1, 2026 4:00 PM - StreetInsider
Wells Fargo Assumes Xencor, Inc. (XNCR) at Overweight
September 30, 2026 6:23 AM - StreetInsider
Xencor, Inc. (XNCR) PT Raised to $29 at Truist Securities
September 28, 2026 7:11 AM - StreetInsider
Xencor, Inc. (XNCR) PT Raised to $35 at Barclays
September 11, 2026 5:30 AM - StreetInsider
Xencor, Inc. (XNCR) PT Raised to $21 at JPMorgan
September 3, 2026 8:32 AM - StreetInsider
Xencor to Present at the 2026 Cantor Global Healthcare Conference
September 2, 2026 4:01 PM - BizWire
Piper Sandler on Biotechnology: 'Look for Biotech to Outperform through YE:26'
September 1, 2026 9:07 AM - StreetInsider
Xencor, Inc. (XNCR) PT Raised to $20 at RBC Capital
August 6, 2026 6:59 AM - StreetInsider
Xencor (XNCR) Tops Q2 EPS by 51c
August 5, 2026 4:03 PM - StreetInsider
Form 10-Q Xencor Inc For: Jun 30
August 5, 2026 4:02 PM - SEC Filing
Form 8-K Xencor Inc For: Aug 05
August 5, 2026 4:01 PM - SEC Filing
Xencor Reports Second Quarter 2026 Financial Results
August 5, 2026 4:01 PM - BizWire
William Blair Updates Analyst Conviction List For August 2026
August 3, 2026 5:23 AM - StreetInsider
Form SCHEDULE 13G Xencor Inc Filed by: VANGUARD CAPITAL MANAGEMENT LLC
July 31, 2026 10:46 AM - SEC Filing
Form 8-K Xencor Inc For: Jul 29
July 29, 2026 4:06 PM - SEC Filing
Xencor to receive $105M from Alexion in Ultomiris royalty settlement
July 29, 2026 4:02 PM - StreetInsider
Xencor to Receive $105 Million From Alexion to Resolve Ultomiris® U.S. Royalty Matter
July 29, 2026 4:01 PM - BizWire
Full Article List